FDMT logo

FDMT Operating Expenses

Annual Operating Expenses

$187.88 M
+$54.29 M+40.64%

December 1, 2024


Summary


Performance

FDMT Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFDMTexpensesmetrics:

Quarterly Operating Expenses

$56.12 M
+$4.98 M+9.74%

December 1, 2024


Summary


Performance

FDMT Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFDMTexpensesmetrics:

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

FDMT Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+40.6%+32.2%
3 y3 years+110.2%+64.2%
5 y5 years+257.1%+64.2%

FDMT Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+110.2%at high+125.8%
5 y5-yearat high+257.1%at high+268.3%
alltimeall timeat high+1001.1%at high+351.6%

4D Molecular Therapeutics Operating Expenses History

DateAnnualQuarterly
Dec 2024
$187.88 M(+40.6%)
$56.12 M(+9.7%)
Sep 2024
-
$51.13 M(+20.4%)
Jun 2024
-
$42.46 M(+11.3%)
Mar 2024
-
$38.16 M(+4.2%)
Dec 2023
$133.59 M(+18.1%)
$36.63 M(+7.2%)
Sep 2023
-
$34.18 M(+5.6%)
Jun 2023
-
$32.38 M(+6.5%)
Mar 2023
-
$30.40 M(+1.5%)
Dec 2022
$113.16 M(+26.6%)
$29.97 M(+11.0%)
Sep 2022
-
$27.00 M(-5.6%)
Jun 2022
-
$28.59 M(+3.5%)
Mar 2022
-
$27.61 M(+11.1%)
DateAnnualQuarterly
Dec 2021
$89.37 M(+27.2%)
$24.86 M(+3.5%)
Sep 2021
-
$24.03 M(+8.3%)
Jun 2021
-
$22.18 M(+21.1%)
Mar 2021
-
$18.31 M(-5.8%)
Dec 2020
$70.28 M(+33.6%)
$19.45 M(+27.6%)
Sep 2020
-
$15.24 M(-18.9%)
Jun 2020
-
$18.78 M(+11.7%)
Mar 2020
-
$16.81 M(-8.2%)
Dec 2019
$52.61 M(+114.5%)
$18.32 M(+47.4%)
Sep 2019
-
$12.43 M
Dec 2018
$24.53 M(+43.8%)
-
Dec 2017
$17.06 M
-

FAQ

  • What is 4D Molecular Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for 4D Molecular Therapeutics?
  • What is 4D Molecular Therapeutics annual operating expenses year-on-year change?
  • What is 4D Molecular Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for 4D Molecular Therapeutics?
  • What is 4D Molecular Therapeutics quarterly operating expenses year-on-year change?

What is 4D Molecular Therapeutics annual total operating expenses?

The current annual operating expenses of FDMT is $187.88 M

What is the all time high annual operating expenses for 4D Molecular Therapeutics?

4D Molecular Therapeutics all-time high annual total operating expenses is $187.88 M

What is 4D Molecular Therapeutics annual operating expenses year-on-year change?

Over the past year, FDMT annual total operating expenses has changed by +$54.29 M (+40.64%)

What is 4D Molecular Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of FDMT is $56.12 M

What is the all time high quarterly operating expenses for 4D Molecular Therapeutics?

4D Molecular Therapeutics all-time high quarterly total operating expenses is $56.12 M

What is 4D Molecular Therapeutics quarterly operating expenses year-on-year change?

Over the past year, FDMT quarterly total operating expenses has changed by +$13.66 M (+32.16%)